T. Daniel

发表

Emerging targets: molecular mechanisms of cell contact-mediated growth control.

P. Nelson, T. Daniel, 2002, Kidney international.

Platelet-derived growth factor receptors and phospholipase C activation.

T. Daniel, D. A. Kumjian, 1992, Kidney international.

Phospholipase C gamma complexes with ligand-activated platelet-derived growth factor receptors. An intermediate implicated in phospholipase activation.

S. Rhee, T. Daniel, D. A. Kumjian, 1991, The Journal of biological chemistry.

Origins and formation of microvasculature in the developing kidney.

P. S. St. John, D. Abrahamson, B. Robert, 1998, Kidney international. Supplement.

A novel TNF receptor family member binds TWEAK and is implicated in angiogenesis.

C. Smith, J. Winkles, W. Fanslow, 2001, Immunity.

Detergent solubility defines an alternative itinerary for a subpopulation of PDGF β receptors

W. Pledger, S. Coats, M. Awazu, 1996, Journal of cellular physiology.

Thrombin stimulates c-sis gene expression in microvascular endothelial cells.

L. Williams, M. Garovoy, D. Milfay, 1986, The Journal of biological chemistry.

A monoclonal antibody against CD 148 , a receptor-like tyrosine phosphatase , inhibits endothelial-cell growth and angiogenesis

Keiko Takahashi, R. Mernaugh, Takamune Takahashi, 2006 .

Vascular Endothelial Growth Factor Effects on Nuclear Factor-k B Activation in Hematopoietic Progenitor Cells 1

D. Carbone, T. Oyama, S. Nadaf, 2001 .

Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis.

G. Yancopoulos, Jin Chen, D. Brantley, 2002, Molecular cancer research : MCR.

Spatial organization of the extracellular matrix modulates the expression of PDGF-receptor subunits in mesangial cells.

M. Kashgarian, J. Madri, T. Daniel, 1993, Kidney international.

Advances in Brief Thromboxane A 2 Is a Mediator of Cyclooxygenase-2-dependent Endothelial Migration and Angiogenesis 1

J. Morrow, L. Marnett, Hua Liu, 1999 .

Thromboxane A2 is a mediator of cyclooxygenase-2-dependent endothelial migration and angiogenesis.

J. Morrow, L. Marnett, H. Liu, 1999, Cancer research.

Vascular origin determines plasminogen activator expression in human endothelial cells. Renal endothelial cells produce large amounts of single chain urokinase type plasminogen activator.

J. Wojta, R. Hoover, T. Daniel, 1989, The Journal of biological chemistry.

Cyclosporin A inhibits kinase C-independent activation of the Na+/H+ exchanger by PDGF and vanadate.

H. Ives, T. Daniel, 1987, Biochemical and biophysical research communications.

Visualization of lipoprotein receptors by ligand blotting.

M. Brown, J. Goldstein, W. Schneider, 1983, The Journal of biological chemistry.

Temporally compartmentalized expression of ephrin-B2 during renal glomerular development.

D. Anderson, S. Gerety, T. Daniel, 2001, Journal of the American Society of Nephrology : JASN.

Ephrin-B1 transduces signals to activate integrin-mediated migration, attachment and angiogenesis.

Junya Chen, D. Cerretti, U. Huynh-Do, 2002, Journal of cell science.

Antiphosphotyrosine recovery of phospholipase C activity after EGF treatment of A-431 cells.

G. Carpenter, M. Wahl, T. Daniel, 1988, Science.

Agents that increase cAMP accumulation block endothelial c-sis induction by thrombin and transforming growth factor-beta.

L. Williams, D. Milfay, T. Daniel, 1987, The Journal of biological chemistry.

Endothelial heterogeneity in Shiga toxin receptors and responses.

C. Lingwood, T. Obrig, B. Boyd, 1993, The Journal of biological chemistry.

Interrelationship between growth factor-induced pH changes and intracellular Ca2+.

H. Ives, T. Daniel, 1987, Proceedings of the National Academy of Sciences of the United States of America.

Epidermal growth factor binding, stimulation of phosphorylation, and inhibition of gluconeogenesis in rat proximal tubule

R. Harris, R.C. Harris, T. Daniel, 1989, Journal of cellular physiology.

The PDGF Receptor As A Mediator of Mitogenesis

S. Coughlin, M. Keating, J. Escobedo, 1987 .

Potential role for Duffy antigen chemokine‐binding protein in angiogenesis and maintenance of homeostasis in response to stress

R. Strieter, A. Richmond, L. Nanney, 2002, Journal of leukocyte biology.

Purification of the platelet-derived growth factor receptor by using an anti-phosphotyrosine antibody.

L. Williams, A. Frackelton, T. Daniel, 1985, Proceedings of the National Academy of Sciences of the United States of America.

5' untranslated sequences determine degradative pathway for alternate PDGF B/c-sis mRNA's.

T. Daniel, Z. Fen, Daniel To, 1991, Oncogene.

Structure of the receptor for platelet-derived growth factor helps define a family of closely related growth factor receptors

A. Ullrich, U. Francke, Y. Yarden, 1986, Nature.

Platelet-derived growth factor (PDGF) binding promotes physical association of PDGF receptor with phospholipase C.

S. Rhee, M. Wahl, T. Daniel, 1989, Proceedings of the National Academy of Sciences of the United States of America.

Reverse endocytosis of transmembrane ephrin-B ligands via a clathrin-mediated pathway.

R. Roberts, M. Parker, Takamune Takahashi, 2004, Biochemical and biophysical research communications.

Biochemical and functional discrimination of platelet-derived growth factor alpha and beta receptors in BALB/c-3T3 cells.

W. Pledger, N. Olashaw, T. Daniel, 1991, The Journal of biological chemistry.

Endothelial localization of receptor tyrosine phosphatase, ECRTP/DEP-1, in developing and mature renal vasculature.

D. Abrahamson, R. Mernaugh, V. Drozdoff, 1999, Journal of the American Society of Nephrology : JASN.

The CXC Chemokine Receptor 2, CXCR2, Is the Putative Receptor for ELR+ CXC Chemokine-Induced Angiogenic Activity1

M. Burdick, R. Strieter, C. Addison, 2000, The Journal of Immunology.

Vascular Endothelial Growth Factor Effects on Nuclear Factor-κB Activation in Hematopoietic Progenitor Cells

D. Carbone, T. Oyama, S. Nadaf, 2001 .

Surface densities of ephrin‐B1 determine EphB1‐coupled activation of cell attachment through αvβ3 and α5β1 integrins

A. Lane, D. Cerretti, U. Huynh-Do, 1999 .

Surface densities of ephrin-B1 determine EphB1-coupled activation of cell attachment through alphavbeta3 and alpha5beta1 integrins.

A. Lane, D. Cerretti, U. Huynh-Do, 1999, The EMBO journal.

Eph receptors discriminate specific ligand oligomers to determine alternative signaling complexes, attachment, and assembly responses.

A. Lane, D. Cerretti, R. V. Van Etten, 1998, Genes & development.

Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, β-catenin, and the phosphatase DEP-1/CD148

M. Corada, F. Orsenigo, F. Breviario, 2003, The Journal of cell biology.

High-efficiency and low-toxicity adenovirus-assisted endothelial transfection.

T. Daniel, T. Takahashi, K. Takahashi, 1999, Methods in molecular medicine.

Nck-Interacting Ste20 Kinase Couples Eph Receptors to c-Jun N-Terminal Kinase and Integrin Activation

T. Pawson, E. Skolnik, U. Huynh-Do, 2000, Molecular and Cellular Biology.

Nck Recruitment to Eph Receptor, EphB1/ELK, Couples Ligand Activation to c-Jun Kinase*

A. Lane, D. Cerretti, U. Huynh-Do, 1998, The Journal of Biological Chemistry.

Identification of a subpopulation of human renal microvascular endothelial cells with capacity to form capillary-like cord and tube structures

T. Daniel, J. McKanna, L. Barley-Maloney, 1997, In Vitro Cellular & Developmental Biology - Animal.

Renal microvascular assembly and repair: power and promise of molecular definition.

U. Huynh-Do, T. Daniel, T. Takahashi, 1998, Kidney international.

A western blot assay detects autoantibodies to cryptic endothelial antigens in thrombotic microangiopathies

T. Daniel, L. Barley-Maloney, D. Koenig, 1993, Journal of Clinical Immunology.

A monoclonal antibody against CD148, a receptor-like tyrosine phosphatase, inhibits endothelial-cell growth and angiogenesis.

Keiko Takahashi, R. Mernaugh, Takamune Takahashi, 2006, Blood.

Endothelial signal integration in vascular assembly.

D. Abrahamson, T. Daniel, 2000, Annual review of physiology.

EphB1 recruits c-Src and p52Shc to activate MAPK/ERK and promote chemotaxis

D. Cerretti, U. Huynh-Do, C. Vindis, 2003, The Journal of cell biology.

A Mutant Receptor Tyrosine Phosphatase, CD148, Causes Defects in Vascular Development

Paul A. Fleming, P. S. St. John, D. Abrahamson, 2003, Molecular and Cellular Biology.

Studies of ligand-induced site-specific phosphorylation of epidermal growth factor receptor

Richard S. Johnson, D. Cerretti, C. Kozlosky, 2003, Journal of the American Society for Mass Spectrometry.

Ligand Activation of ELK Receptor Tyrosine Kinase Promotes Its Association with Grb10 and Grb2 in Vascular Endothelial Cells*

D. Cerretti, T. Daniel, E. Stein, 1996, The Journal of Biological Chemistry.

Eph family receptors and ligands in vascular cell targeting and assembly.

T. Daniel, H. Schoecklmann, E. Stein, 1997, Trends in cardiovascular medicine.

219 Human renal microvascular redothelial cells (HRMEC) express large amounts of scuPA

J. Wojta, R. Hoover, T. Daniel, 1988 .

Vascular endothelial growth factor effects on nuclear factor-kappaB activation in hematopoietic progenitor cells.

D. Carbone, T. Oyama, S. Nadaf, 2001, Cancer Research.

Distinct pathways mediate transcriptional regulation of platelet-derived growth factor B/c-sis expression.

T. Daniel, Z. Fen, 1988, The Journal of biological chemistry.

Biosynthetic and glycosylation studies of cell surface platelet-derived growth factor receptors.

J. Escobedo, L. Williams, D. Milfay, 1987, The Journal of biological chemistry.

ELK and LERK-2 in developing kidney and microvascular endothelial assembly.

P. S. St. John, D. Abrahamson, D. Cerretti, 1996, Kidney international. Supplement.

Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, β-catenin, and the phosphatase DEP-1/CD148

M. Corada, F. Orsenigo, F. Breviario, 2003, The Journal of cell biology.

Thromboxane A2 is a mediator of COX-2 dependent endothelial migration & angiogenesis

J. Morrow, Hua Liu, T. Daniel, 1999 .